Posted by Michael Wonder on 26 Mar 2019
EMA tells pharma companies to continue to prepare for UK’s withdrawal
25 March 2019 - With an extension in place that will push the UK's withdrawal from the EU back to either April or May, the EMA told pharmaceutical companies on Monday to continue their preparations for Brexit.
Under the European Council decision from last Friday, if the withdrawal agreement between the UK and the EU is approved by the UK House of Commons by 29 March 2019, the extension will be until 22 May 2019. But if the withdrawal agreement is not approved by 29 March 2019, the extension will be until 12 April 2019.
“The decision makes clear that the UK remains a Member State for the duration of the extension, with all the rights and obligations set out in the treaties and under EU law,” EMA said.
